Skip to main content
. Author manuscript; available in PMC: 2021 May 11.
Published in final edited form as: ACS Biomater Sci Eng. 2019 Sep 23;6(5):2588–2599. doi: 10.1021/acsbiomaterials.9b00895

Figure 6.

Figure 6.

Average percentage of cell types within central, mid, and outer regions of vessel cross sections treated with IMPEDE, AVP, and Nester devices. Note: The vessel implanted with AVP at 60 days was not scored due to the presence of extensive intradevice vascular channels. Additionally, multinucleated giant cells were assessed qualitatively and are not reflected in this figure; however, they are reflected in the healing score assigned (defined in Table 2).